Brainstorm Cell Therapeutics Inc. financial data

Symbol
BCLI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1325 Avenue Of Americas, 28 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
GOLDEN HAND RESOURCES INC (to 11/22/2004), WIZBANG TECHNOLOGIES INC (to 8/8/2003)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 19 % -19%
Debt-to-equity -156 % +36.3%
Return On Equity 203 % -52.3%
Return On Assets -361 % -23.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.52M shares -90.5%
Common Stock, Shares, Outstanding 6.14M shares +52.3%
Entity Public Float 25.5M USD
Common Stock, Value, Issued 14K USD +7.69%
Weighted Average Number of Shares Outstanding, Basic 5.02M shares +74.9%
Weighted Average Number of Shares Outstanding, Diluted 5.02M shares +74.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.65M USD -56.7%
General and Administrative Expense 7.04M USD -34.1%
Operating Income (Loss) -11.7M USD +45.5%
Net Income (Loss) Attributable to Parent -11.6M USD +32.4%
Earnings Per Share, Basic -2.31 USD/shares +61.5%
Earnings Per Share, Diluted -2.31 USD/shares +61.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 187K USD -85.6%
Assets, Current 385K USD -79.7%
Property, Plant and Equipment, Net 434K USD -36.7%
Operating Lease, Right-of-Use Asset 807K USD -43%
Other Assets, Noncurrent 1.45M USD -37.3%
Assets 1.83M USD -56.5%
Accounts Payable, Current 6.08M USD +22.7%
Employee-related Liabilities, Current 1.43M USD +42.6%
Accrued Liabilities, Current 619K USD -50.1%
Liabilities, Current 8.98M USD +15.1%
Operating Lease, Liability, Noncurrent 171K USD -74.6%
Liabilities 9.6M USD +5.85%
Retained Earnings (Accumulated Deficit) -227M USD -5.41%
Stockholders' Equity Attributable to Parent -7.76M USD -59.8%
Liabilities and Equity 1.83M USD -56.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.09M USD +55.6%
Net Cash Provided by (Used in) Financing Activities 17.4M USD -17.5%
Net Cash Provided by (Used in) Investing Activities 2.19M USD +120%
Common Stock, Shares Authorized 250M shares +150%
Common Stock, Shares, Issued 6.14M shares +52.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.11M USD -256%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 371K USD -75%
Deferred Tax Assets, Valuation Allowance 56.2M USD +10.7%
Deferred Tax Assets, Gross 56.2M USD +10.7%
Operating Lease, Liability 720K USD -43.5%
Depreciation 240K USD -9.43%
Payments to Acquire Property, Plant, and Equipment 18K USD +1700%
Lessee, Operating Lease, Liability, to be Paid 761K USD -44.7%
Property, Plant and Equipment, Gross 3.44M USD -0.35%
Operating Lease, Liability, Current 549K USD -8.96%
Lessee, Operating Lease, Liability, to be Paid, Year Two 188K USD -67.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 573K USD -6.22%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 41K USD -59.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 189K USD -86%
Lessee, Operating Lease, Liability, to be Paid, Year Four 179K USD -7.25%
Operating Lease, Payments 166K USD -57%